1-3 of 3
Kaini Shen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Patients with Mayo 2004 Stage 3 Light-Chain Amyloidosis: A Prospective Phase 2 Study

Ya-Juan Gao, Kaini Shen, Long Chang, Jun Feng, Yueying Mao, Lu Zhang, Xinxin Cao, Daobin Zhou, Jian Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 4391–4392.
https://doi.org/10.1182/blood-2022-157044
Published: 2022
Journal Articles

Doxycycline Combined with Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Patients with Mayo 2004 Stage II-III Light-Chain Amyloidosis: A Randomized Controlled Multicenter Study

Kaini Shen, MD, Yujun Dong, MD, Weijun Fu, Sr., MD PhD, Yu Wu, MD, Zhongxia Huang, Yongqiang Wei, PhD, Chunrui Li, MD PhD, Chunyan Sun, MD PhD, Wenrong Huang, Huihan Wang, MD PhD, Congli Zhang, Huilei Miao, Lu Zhang, MD, Xinxin Cao, MD, Daobin Zhou, MD, Jian Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1870.
https://doi.org/10.1182/blood-2019-122087
Published: 2019
Journal Articles

Bortezomib-Based Chemotherapy Reduces Early Mortality and Improves Outcomes in Patients with Ultra-High-Risk Light-Chain Amyloidosis

Kaini Shen, Congli Zhang, Jun Feng, MD, Lu Zhang, Xinxin Cao, Daobin Zhou, MD, Jian Li, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3304.
https://doi.org/10.1182/blood-2018-99-112407
Published: 2018